CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities
Net loss	$ (21,821,953)	$ (20,242,630)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	102,110	60,608
Non-cash interest expense	720,963	1,733,521
Non-cash lease expense	189,424	250,361
In-process research and development	7,000,000	0
Change in fair value of derivative liability	0	3,187,380
Stock-based compensation expense	660,317	884,089
Loss on debt conversion	0	341,136
Other non-cash	(349,409)	4,803
Changes in assets and liabilities:
Prepaid expenses and other current assets	(369,846)	(1,007,367)
Accounts payable and accrued expenses	(540,847)	(1,628,621)
Other assets	(104,000)	(227,172)
Lease obligations	(195,489)	(249,389)
Net cash used in operating activities	(14,708,730)	(16,893,281)
Cash flows from investing activities
Purchase of property and equipment	(306,825)	(29,446)
Payment of reverse asset acquisition costs	0	(2,327,273)
Net cash used in investing activities	(306,825)	(2,356,719)
Cash flows from financing activities
Financing lease principal payments	(23,856)	(25,866)
Proceeds from issuance of common stock	37,822,025	1,183,034
Payment of equity issuance costs	(1,477,806)	0
Proceeds from issuance of debt	921,415	6,800,000
Payments of debt issuance costs	(5,740)	(99,202)
Repayments of debt	(5,625,000)	(5,290,000)
Purchases of treasury stock	0	(47,864)
Proceeds from Pre-Merger Financing	0	22,546,353
Net cash provided by financing activities	31,611,038	25,066,455
Net increase in cash, cash equivalents and restricted cash	16,595,483	5,816,455
Cash, cash equivalents and restricted cash at beginning of period	7,595,068	1,778,613
Cash, cash equivalents and restricted cash at end of period	24,190,551	7,595,068
Supplemental disclosure of non-cash transactions:
Issuance of Warrant Exchange Promissory Notes	5,625,000	0
Obligation settled with common stock	331,218	0
Purchase of property and equipment	213,625	0
Conversion of convertible notes	0	13,979,788
Right-of-use assets related to operating leases	179,599	470,356
Equity issuance costs	4,029	1,150,000
Reverse asset acquisition costs	$ 0	$ 2,252,795